Corbevax is being administered to children in the age group 12-14 in India. This age group got the Indian government's nod to be receive vaccine against the novel coronavirus from 16 March, Wednesday.
These children have to register for getting the vaccine on the CoWIN portal. Here's all you need to know about Corbevax Manufacturer India's third indigenous anti-Covid vaccine has been manufactured by Hyderabad-based Biological E Limited.
Biological E has supplied 5 crore doses of Corbevax to the Centre, which has then distributed the same to states. Indian Government approval and Emergency Use Auhtorisation Corbevax received the emergency use authorization (EUA) from the Drugs Controller General of India (DCGI) in February 2022 for children in the age group of 12 to 18 years.
Earlier in September 2021, Biological E had received the nod to conduct the second and third phases of clinical trials of Corbevax on children and adolescents in the age group of 15-18 years.